10743978

Source:http://linkedlifedata.com/resource/pubmed/id/10743978

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007537
pubmed:issue	2
pubmed:dateCreated	2000-5-10
pubmed:abstractText	This paper describes the rationale for choosing cefaclor for the management of respiratory tract infections.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cefaclor, http://linkedlifedata.com/resource/pubmed/chemical/Cephalosporins, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0149-2918
pubmed:author	pubmed-author:MeyersB RBR
pubmed:issnType	Print
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	154-66
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10743978-Biological Availability, pubmed-meshheading:10743978-Cefaclor, pubmed-meshheading:10743978-Cephalosporins, pubmed-meshheading:10743978-Delayed-Action Preparations, pubmed-meshheading:10743978-Humans, pubmed-meshheading:10743978-Respiratory Tract Infections
pubmed:year	2000
pubmed:articleTitle	Cefaclor revisited.
pubmed:affiliation	Division of Infectious Diseases, Mount Sinai School of Medicine, New York, New York 10029, USA.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't